During the past decade, Pest Megyei Flor Ferenc Korhaz conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 21 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 14 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pest Megyei Flor Ferenc Korhaz" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 4 trials sponsored, "Amgen" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pest Megyei Flor Ferenc Korhaz" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Janssen Biotech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Pest Megyei Flor Ferenc Korhaz" are "Arthritis, Psoriatic" (4 trials), "Colitis, Ulcerative" (3 trials), "Crohn Disease" (3 trials), "Multiple Sclerosis" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Pest Megyei Flor Ferenc Korhaz" in a lesser frequency.

Most popular intervention types in "Pest Megyei Flor Ferenc Korhaz" are "Drug" (40 trials), "Biological" (4 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Etrolizumab" (4 trials), "Guselkumab" (4 trials), "Apremilast 20mg" (2 trials) and "Apremilast 30mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pest Megyei Flor Ferenc Korhaz" are 43 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Pest Megyei Flor Ferenc Korhaz". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Pest Megyei Flor Ferenc Korhaz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pest Megyei Flor Ferenc Korhaz, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Pest Megyei Flor Ferenc Korhaz has several departments that took part in Clinical trials: "Pest Megyei Flor Ferenc Korhaz, Reumatologiai-es Fizioterapias Osztaly" - 3 trials, "Pest Megyei Flor Ferenc Korhaz, Neurologia es Stroke Osztaly" - 2 trials